Recommendations for the management of migraine in paediatric patients

Umberto Balottin1, Cristiano Termine

  • 1Child Neuropsychiatry Unit, Department of Clinical and Biological Sciences, University of Insubria and Macchi Foundation Hospital, Varese, p.zza Biroldi, 19, 21100 Varese, Italy. umberto.balottin@uninsubria.it

Insights

Pediatric migraine management requires personalized strategies. Non-pharmacological approaches like lifestyle changes and behavioral therapy may be more effective than medication for migraine prevention in children and adolescents.

Area of Science:

  • Pediatric Neurology
  • Child Psychiatry
  • Clinical Pharmacology

Background:

  • Migraine is a prevalent and debilitating neurological disorder in children and adolescents.
  • Its pathogenesis involves complex interactions between biological, psychological, and environmental factors.
  • Effective management necessitates tailored strategies considering both pharmacological and non-pharmacological interventions.

Purpose of the Study:

  • To review current evidence on the pharmacological and non-pharmacological management of migraine in pediatric populations.
  • To provide guidance on the appropriate use of acute and prophylactic treatments.
  • To emphasize the importance of a holistic, individualized approach to pediatric migraine care.

Main Methods:

  • Systematic review of existing literature on pediatric migraine treatment.
  • Analysis of efficacy and safety data for various acute and prophylactic medications.
  • Evaluation of non-pharmacological interventions and their role in management.

Main Results:

  • Ibuprofen and acetaminophen are recommended for symptomatic relief in children and adolescents.
  • Sumatriptan nasal spray may be effective for adolescents.
  • Flunarizine shows potential for prophylaxis, while pizotifen and clonidine appear ineffective; data for other agents are conflicting or insufficient.
  • Non-pharmacological interventions are suggested as potentially more effective than pharmacotherapy for migraine prophylaxis.

Conclusions:

  • Individualized treatment plans are crucial for managing pediatric migraine, considering developmental aspects and comorbidities.
  • Non-pharmacological strategies, including trigger avoidance, lifestyle regulation, and psychological therapies, are highly recommended for prophylaxis.
  • Pharmacological options should be carefully selected based on age, symptoms, and available evidence.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.